INKT icon

MiNK Therapeutics (INKT)

NASDAQ

$10.86

-$0.090 (

-0.82%

)

1D
5D
1M
6M
1Y
5Y
After hours

INKT: $10.86 / ₿ 0.0001 BTC / 13976 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$10.95
$6.65 - $76.00
$54.10M
-2.55
$10.41
$15,412.96
4.98M
$10.10 - $10.99
$10.41 - $10.86
No

What is MiNK Therapeutics (INKT)?

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

The MiNK Therapeutics (INKT) stock price has been falling

The MiNK Therapeutics, Inc. Common Stock (INKT) stock after-hours price today is $10.86, reflecting a -0.82% after-hours move since the market last closed. The company’s market capitalization stands at $54.10M, with a daily trading volume of $15.41K shares. For investors tracking price trends, MiNK Therapeutics, Inc. Common Stock stock has ranged between $10.41 and $10.86 today. The previous closing price was $10.95.

Get started with MiNK Therapeutics (INKT)

Ready to get started? Follow the steps below, or read our guide on how to buy MiNK Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy INKT

Search for INKT in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy INKT.

INKT FAQs

INKT is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

INKT is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, MiNK Therapeutics, Inc. Common Stock (INKT) has traded between a low of $6.65 and a high of $76.00.

INKT is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in MiNK Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
INKT icon
INKT

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

LICYQ icon

LICYQ

TSEOF icon

TSEOF

ONCO icon

ONCO

Top losers

Compare the worst-performing stocks of 
the day

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.